We are live on
!
Find out more
VF
Virtu Financial Portfolio holdings
AUM
$3.18B
Turnover
77.45%
1-Year Est. Return
65.92%
This Fund
S&P 500
This Quarter
Est. Return
+4.12%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
–
AUM
$2.02B
AUM Growth
+$1.3B
(+180%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
62.76%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,553
New
2,160
Increased
164
Reduced
123
Closed
87
Avg Time Held Equity + Options
0.1
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.2
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$40.3M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$21M |
| 3 |
ProShares Short VIX Short-Term Futures ETF
SVXY
|
+$19.2M |
| 4 |
AF
Astoria Financial Corporation
AF
|
+$18.7M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$16.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$24.8M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$18.6M |
| 3 |
OKS
Oneok Partners LP
OKS
|
+$15.5M |
| 4 |
ProShares Short S&P500
SH
|
+$9.57M |
| 5 |
Invesco CurrencyShares British Pound Sterling Trust
FXB
|
+$7.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.39% |
| 2 | Financials | 7.24% |
| 3 | Consumer Discretionary | 7% |
| 4 | Healthcare | 6.56% |
| 5 | Technology | 4.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2226
XBiotech
XBIT
$65.9M
| $50K | ﹤0.01% |
+11,527
| New | +$54.4K |
2017 Q3
0 quarters
|
|
|
VYNT
2227
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $50K | ﹤0.01% |
+124
| New | +$64.6K |
2017 Q3
0 quarters
|
|
|
CSLT
2228
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $50K | ﹤0.01% |
+11,584
| New | +$47.7K |
2017 Q3
0 quarters
|
|
|
AST
2229
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
| $50K | ﹤0.01% |
+14,700
| New | +$49.5K |
2017 Q3
0 quarters
|
|
2230
Comstock
LODE
$144M
| $49K | ﹤0.01% |
+1,247
| New | +$56.1K |
2017 Q3
0 quarters
|
|
2231
My Size
MYSZ
$789K
| $49K | ﹤0.01% |
+3
| New | +$67K |
2017 Q3
0 quarters
|
|
2232
SenesTech
SNES
$2.98M
| $49K | ﹤0.01% |
+1
| New | +$144K |
2017 Q3
0 quarters
|
|
|
ARAV
2233
DELISTED
Aravive, Inc. Common Stock
ARAV
| $49K | ﹤0.01% |
+3,351
| New | +$338K |
2017 Q3
0 quarters
|
|
2234
Diana Shipping
DSX
$316M
| $48K | ﹤0.01% |
+19,009
| New | +$52.9K |
2017 Q3
0 quarters
|
|
2235
Tsakos Energy Navigation Ltd
TEN
$1.57B
| $48K | ﹤0.01% |
+2,153
| New | +$50.4K |
2017 Q3
0 quarters
|
|
2236
DELISTED
Scorpius Holdings, Inc.
SCPX
| – | – |
0
| – | – |
2017 Q3
0 quarters
|
|
2237
Fury Gold Mines
FURY
$97.5M
| $47K | ﹤0.01% |
+14,172
| New | +$53.7K |
2017 Q3
0 quarters
|
|
2238
Lineage Cell Therapeutics
LCTX
$251M
| $46K | ﹤0.01% |
+18,543
| New | +$46K |
2017 Q3
0 quarters
|
|
|
ONCS
2239
DELISTED
OncoSec Medical Incorporated
ONCS
| $46K | ﹤0.01% |
+217
| New | +$48.4K |
2017 Q3
0 quarters
|
|
|
WIN
2240
DELISTED
Windstream Holdings Inc
WIN
| $46K | ﹤0.01% |
+5,188
| New | +$68.8K |
2017 Q3
0 quarters
|
|
2241
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $45K | ﹤0.01% |
+35,862
| New | +$45.8K |
2017 Q3
0 quarters
|
|
|
FSNN
2242
DELISTED
Fusion Connect, Inc. Common Stock
FSNN
| $45K | ﹤0.01% |
+10,997
| New | +$31.1K |
2017 Q3
0 quarters
|
|
|
TMBR
2243
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $43K | ﹤0.01% |
+10
| New | +$51.4K |
2017 Q3
0 quarters
|
|
|
PQ
2244
DELISTED
Petroquest Energy Inc Wd
PQ
| $43K | ﹤0.01% |
+18,575
| New | +$36.7K |
2017 Q3
0 quarters
|
|
|
ROKA
2245
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
| $43K | ﹤0.01% |
+58,663
| New | +$106K |
2017 Q3
0 quarters
|
|
|
NSU
2246
DELISTED
Nevsun Resources Ltd.
NSU
| $43K | ﹤0.01% |
+19,854
| New | +$46.2K |
2017 Q3
0 quarters
|
|
|
SYNC
2247
DELISTED
Synacor, Inc.
SYNC
| $42K | ﹤0.01% |
+15,486
| New | +$47.2K |
2017 Q3
0 quarters
|
|
|
ABIL
2248
DELISTED
Ability Inc
ABIL
| $42K | ﹤0.01% |
+5,880
| New | +$48.3K |
2017 Q3
0 quarters
|
|
2249
DELISTED
Repros Therapeutics Inc.
RPRX
| $42K | ﹤0.01% |
+132,445
| New | +$46.5K |
2017 Q3
0 quarters
|
|
2250
CareCloud
CCLD
$81.6M
| $41K | ﹤0.01% |
+27,622
| New | +$38.6K |
2017 Q3
0 quarters
|
|
Similar funds
GM
TA
CI
GIA
NSLI
Virtu Financial's Q3 2017 Portfolio in Review
As of Q3 2017, Virtu Financial held 2,553 positions worth $2.02B, up 180% from $721M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Virtu Financial deployed $1.27B of net new capital in Q3 2017, opening 2,160 new positions and adding to 164 existing holdings. Its largest new stake was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 79% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $24.8M trimmed.
- Virtu Financial's largest Q3 2017 buy was State Street DoubleLine Total Return Tactical ETF: 338,092 shares worth $16.7M.
- Virtu Financial added most to VanEck Gold Miners ETF in Q3 2017, an estimated $40.3M increase.
- Virtu Financial's biggest Q3 2017 reduction was Vanguard S&P 500 ETF, cutting an estimated $24.8M.
- Virtu Financial fully exited Oneok Partners LP in Q3 2017, selling an estimated $15.5M.
- Virtu Financial's ten largest holdings make up 17% of its $2.02B portfolio in Q3 2017.
- Virtu Financial opened 2,160 new positions and closed 87 in Q3 2017.
- Virtu Financial's portfolio value rose 180% quarter-over-quarter to $2.02B.
Based on Virtu Financial's 13F filing for Q3 2017, filed 15 Nov 2017.